β‐galactosidase deficiency: Prolonged survival in three patients following early central nervous system deterioration
- 1 March 1978
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 13 (3) , 305-313
- https://doi.org/10.1111/j.1399-0004.1978.tb01185.x
Abstract
Three adult patients from two families have shown slowly progressive neurologic deterioration since the age of 3 years, associated with profound β-galactosidase deficiency. Although affected individuals from the two different families differ in degree of intellectual deficit, facial coarseness and spondyloepiphyseal dysplasia, all lack visceromegaly and macular red spots. The diversity of phenotypic expression in these patients and others previously reported suggests the existence of composite genotypes (compound and double heterozygosity).This publication has 12 references indexed in Scilit:
- β-Galactosidase deficiency in an adult: A biochemical and somatic cell genetic study on a variant of GM1-gangIiosidosisClinical Genetics, 2008
- Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid β‐galactosidase deficiencyClinical Genetics, 1976
- The Iduronidase-Deficient Mucopolysaccharidoses: Clinical and Roentgenographic FeaturesPublished by American Academy of Pediatrics (AAP) ,1976
- Molecular genetics of GM1β‐galactosidaseClinical Genetics, 1975
- Genetic heterogeneity in GM1-gangliosidosisNature, 1975
- BETA-GALACTOSIDASE DEFICIENCY IN YOUNG ADULTSThe Lancet, 1974
- Localized ß-Galactosidase DeficiencyArchives of internal medicine (1960), 1974
- Juvenile GM1 GangliosidosisArchives of Neurology, 1974
- A New Type of Mucolipidosis with β-Galactosidase Deficiency and GlycopeptiduriaThe Tohoku Journal of Experimental Medicine, 1972
- Macular Cherry-Red Spot, Corneal Clouding, and ß-Galactosidase DeficiencyArchives of internal medicine (1960), 1971